Table: Oncolys Biopharma - 9-MTH parent results

Oncolys Biopharma

02/11/2018 06:00

Nov 2 (Reuters)- 
             Oncolys Biopharma Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to   
                Sep 30, 2018        Sep 30, 2017       Dec 31, 2018  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            118 mln             29 mln            230 mln     
                (+308.0 pct)         (-37.6 pct)        (+0.4 pct)   
  Operating     loss 915 mln        loss 768 mln        loss 1.40    
  Recurring     loss 899 mln        loss 776 mln        loss 1.40    
  Net           loss 901 mln        loss 779 mln        loss 1.40    
  EPS          loss 79.31 yen      loss 77.81 yen    loss 126.29 yen 
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
  
  NOTE - Oncolys Biopharma Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T